Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study

This article was originally published at https://www.drugpatentwatch.com/blog/affordability-and-availability-of-off-patent-drugs-in-the-united-states-the-case-for-importing-from-abroad-observational-study/

This article was originally published by Ravi Gupta, Thomas J Bollyky, Matthew Cohen, Joseph S Ross, and Aaron S Kesselheim  in BMJ 2018;360:k831 under a Creative Commons Attribution Non Commercial (CC BY-NC… The post Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study appeared first on DrugPatentWatch.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog